Thu, March 28, 2024
Wed, March 27, 2024
Tue, March 26, 2024

Robert Driscoll Maintained (APRE) at Buy with Increased Target to $11 on, Mar 27th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-11-on-mar-27th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Robert Driscoll of Wedbush, Maintained "Aprea Therapeutics, Inc." (APRE) at Buy with Increased Target from $9 to $11 on, Mar 27th, 2024.

Robert has made no other calls on APRE in the last 4 months.



There is 1 other peer that has a rating on APRE. Out of the 1 peers that are also analyzing APRE, 0 agree with Robert's Rating of Hold.



This is the rating of the analyst that currently disagrees with Robert


  • Joseph Pantginis of "HC Wainwright & Co." Maintained at Strong Buy and Held Target at $20 on, Tuesday, March 26th, 2024

Publication Contributing Sources